Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

31 - 40 von 77

	31	Monopolistic competition, auction and authorization: a Schumpeterian view of leadership and the political market Enthalten in Historical social research Bd. 37, 2012, Nr. 1: 57-72
	32	Impact of generic competition on market share and prices of cardiovascular medicines on the Bulgarian pharmaceutical market Manova, Manoela M.. - Mannheim, 2010
	33	Communicating risks of foodborne diseases Enthalten in Open medicine Bd. 1, 2006, Nr. 1: 69-80. 12 S.
	34	A manipulative technique of Andrew Taylor Still as reported by Charles Hazzard, DO, in 1905 Enthalten in Journal of osteopathic medicine Bd. 96, 1996, Nr. 10: 597-597. 6 S.
	35	A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China Enthalten in BMC health services research Bd. 13, 5.10.2013, Nr. 1, date:12.2013: 1-8
	36	A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer Enthalten in BMC medicine Bd. 23, 9.5.2025, Nr. 1, date:12.2025: 1-9
	37	A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study Enthalten in BMC pharmacology & toxicology Bd. 14, 5.1.2013, Nr. 1, date:12.2013: 1-19
	38	Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin–Metformin Fixed-Dose Combination Compared with the Originator Products Enthalten in Diabetes therapy Bd. 14, 16.12.2022, Nr. 2, date:2.2023: 347-362
	39	Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers Enthalten in Diabetes therapy Bd. 13, 11.5.2022, Nr. 6, date:6.2022: 1215-1229
	40	Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M) Enthalten in Diabetes therapy Bd. 13, 14.4.2022, Nr. 5, date:5.2022: 1053-1071